Pathogenesis of anemia in cardiorenal disease

Reviews in Cardiovascular Medicine

Volumn 6, Issue SUPPL. 3, 2005, Pages

  Anand, Inder S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Anemia; Chronic heart failure; Chronic kidney disease; Erythropoietin; SOLVD; Val HeFT

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CARDIOVASCULAR AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; HEMOGLOBIN; NEUROHORMONE; OXYGEN; TUMOR NECROSIS FACTOR ALPHA;

AGING; ANEMIA; ARTICLE; CACHEXIA; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; EXERCISE TEST; FLUID RETENTION; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEMODILUTION; HEMOGLOBIN DETERMINATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; MORBIDITY; MORTALITY; NEUTROPHIL; PATHOGENESIS; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TISSUE OXYGENATION; VASODILATATION;

ANEMIA; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 28644437526     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-962.
2. Gottlieb SS, Abraham W, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail. 2002;8:136-141.
3. McClellan WM, Flanders WD, Langston RD, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol. 2002;13:1928-1936.
4. Collins AJ, Li S, St Peter W, et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol. 2001; 12:2465-2473.
5. Komajda M. Prevalence of anemia in patients with chronic heart failure and their clinical characteristics. J Card Fail. 2004;10:S1-S4.
6. McMurray JJ. What are the clinical consequences of anemia in patients with chronic heart failure? J Card Fail. 2004;10:S10-S12.
7. Dallman PR. Iron Nutrition in Health and Disease. London: John Libbey & Co; 1996.
8. Sarnak MJ, Tighiouart H, Manjunathg, et al. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol. 2002; 40:27-33.
9. McClellan W, Aronoff SL, Bolton WK, et al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Res Opin. 2004;20: 1501-1510.
10. Isham A, Weinhandl E, Zhao Z, et al. Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2005;45:391-399.
11. Anand IS, Kuskowski MA, Rector TS, et al. Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: Results from Val-HeFT. Circulation. 2005 (in press).
12. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-1786.
13. Anand I, McMurray JJ, Whitmore J, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110:149-154.
14. Maggioni AP, Opasich C, Anand I, et al. Anemia in patients with heart failure: Prevalence and prognostic role in a controlled trial and in clinical practice. J Card Fail. 2005;11:91-98.
15. Brucks S, Little WC, Chao T, et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol. 2004;93:1055-1057.
16. Nair D, Shlipak MG, Angeja B, et al. Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study. Am J Cardiol. 2005;95: 332-336.
17. Volpe M, Tritto C, Testa U, et al. Blood levels of erythropoietin in congestive heart failure and correlation with clinical, hemodynamic, and hormonal profiles. Am J Cardiol. 1994;74: 468-473.
18. George J, Patal S, Wexler D, et al. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers. Arch Intern Med. 2005;165:1304-1309.
19. Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine data-base from the Vesnarinone trial (VEST). Circulation. 2001;103:2055-2059.
20. Anand IS, Latini R, Florea VG, et al. C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation. 2005; (in press).
21. Albitar S, Genin R, Fen-Chong M, et al. High dose enalapril impairs the response to erythropoietin treatment in haemodialysis patients. Nephrol Dial Transplant. 1998;13: 1206-1210.
22. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? Heart. 2002;87:377-378.
23. Witte KK, Desilva R, Chattopadhyay S, et al. Are hematinic deficiencies the cause of anemia in chronic heart failure? Am Heart J. 2004;147: 924-930.
24. Anker SD, Chua TP, Ponikowski P, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526-534.
25. Androne AS, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-229.
26. Adamson JW. Regulation of red blood cell production. Am J Med. 1996;101:4S-6S.
27. Anand IS, Chandrashekhar Y, Ferrari R, et al. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J. 1993;70:357-362.
28. Anand IS, Florea VG. High output cardiac failure. Current Treatment Options in Cardiovascular Medicine. 2001;3:151-159.
29. Anand IS, Ferrari R, Kalra GS, et al. Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation. 1989;80:299-305.
30. Anand IS, Chandrashekhar Y, Wander GS, Chawla LS. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. J Am Coll Cardiol. 1995;25:1402-1407.
31. Ni Z, Morcos S, Vaziri ND. Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. Kidney Int. 1997;52:195-201.
32. Olivetti G, Quaini F, Lagrasta C, et al. Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats. Am J Pathol. 1992;141:227-239.
33. Elhendy A, Modesto KM, Mahoney DW, et al. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol. 2003;41:129-135.
34. Deray G, Heurtier A, Grimaldi A, et al. Anemia and diabetes. Am J Nephrol. 2004;24: 522-526.
35. Bosman DR, Winkler AS, Marsden JT, et al. Anemia with erythropoietin deficiency occurs early in diabetic nephropathy. Diabetes Care. 2001; 24:495-499.
36. Winkler AS, Marsden J, Chandhuri KR, et al. Erythropoietin depletion and anaemia in diabetes mellitus. Diabet Med. 2000;17:410.
37. Weiner DE, Tighiouart H, Vlagapoulos PT, et al. Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol. 2005; 16:1803-1810.
38. Philipp S, Ollmann H, Schink T, et al. The impact of anemia and kidney function in congestive heart failure and preserved systolic function. Nephrol Dial Transplant. 2005;20:915-919.
39. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol. 2003;41: 1933-1939.
40. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12, 065 patients with new-onset heart failure. Circulation. 2003;107:223-225.
41. Kosiborod M, Smith GL, Radford MJ, et al. The prognostic importance of anemia in patients with heart failure, Am J Med. 2003;114: 112-119.
42. Silverberg DS, Wexler D, Blum M, et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol. 2000;35:1737-1744.
43. Silverberg DS, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol. 2001;37:1775-1780.
44. Mancini DM, Katz SD, Lang CC, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-299.
45. Besarab A, Bolton WK, Browne JK, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med. 1998;339:584-590.
46. Leyland-Jones B. Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol. 2003;4:459-460.
47. FDA ODACMot. Safety of Erythropoietin Receptor Agonists in Patients with Cancer. www.fda,gov/ohrms/dockets/ac/04/agenda/4037a_final.htm_05-06-2004.
48. Dunlap SH, Pina IL, Cotts WG, et al. for the STAMINA-HFP Investigators. Lower hemoglobin is associated with persistently reduced quality of life in unselected patients with heart failure: Results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry. Abastract 311, presented at the Heart Failure Society of America 8th Annual Scientific Meeting. Toronto, Canada, September 13, 2004.
49. Anker SD, Coats AJS, Roecker EB, et al for the COPERNICUS Study Group. Hemoglobin level is associated with mortality and hospitalization in patients with severe chronic heart failure: Results from the COPERNICUS study. J Am Coll Cordial. 2004;43 (Suppl A):842-2.
50. Sharma R, Francis DP, Pitt B, et al. Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial. Eur Heart J. 2004;25:1021-1028.
51. Szachniewicz J, Petruk-Kowalczyk J, Majda J, et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol. 2003;90:303-308.
52. Tanner H, Moschovitis G, Kuster GM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol. 2002;86:115-121.
53. Wexler D, Silverberg D, Sheps D, et al. Prevalence of anemia in patients admitted to hospital with a primary diagnosis of congestive heart failure. Int J Cardiol. 2004;96:79-87.
54. Felker GM, Adams KF, Jr., Gattis WA, O'Connor CM. Anemia as a risk factor and therapeutic target in heart failure. J Am Coll Cardiol. 2004; 44:959-966.
55. Herzog CA, et al. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. Circulation. 2002;106:2333A.
56. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J. 2003;24:442-463.